The prevalence and evolution of respiratory pathogens are changing, and issues related to drug-resistance are becoming increasingly prominent in the post-COVID era. The urgency of controlling respiratory pathogens has intensified. This issue organizes expert discussions to address the resurgence of various respiratory pathogens, summarizing current status of pathogen surveillance, drug-resistance research and vaccine development, while suggesting countermeasures. It emphasizes the need to integrate of medical and preventive measures, conduct multi-pathogen surveillance and management, enhance the response capacity of respiratory infectious diseases, optimize vaccine policy and immunization services, improve the level of diagnosis and treatment, and strengthen protection for vulnerable populations, so as to reduce the burden of respiratory infectious diseases.
新型冠状病毒感染大流行之后，呼吸道病原体流行强度和特征改变，耐药问题日益凸显，呼吸道病原体防控愈加紧迫。本期重点号以“呼吸道病原防控”为主题，组织多学科专家针对多种呼吸道病原体交替流行的现状，总结各种病原体流行特征、疫苗研发及耐药研究现状，提出应对策略，强调创新医防协同医防融合机制及措施，开展多病原监测与多病共防，提升我国呼吸道传染病防控能力，优化疫苗策略和免疫服务，提高诊疗和管理规范性，加大脆弱人群的保护力度，降低疾病负担。.